






























































Scalable Synthesis of Ultrasmall Metal Oxide Radio-Enhancers
Outperforming Gold
Lukas R.H. Gerken, Anna L. Neuer, Pascal M. Gschwend, Kerda Keevend, Alexander Gogos,
Alexandre H.C. Anthis, Leonie Aengenheister, Sotiris E. Pratsinis, Ludwig Plasswilm,
and Inge K. Herrmann*
Cite This: Chem. Mater. 2021, 33, 3098−3112 Read Online
ACCESS Metrics & More Article Recommendations *sı Supporting Information
ABSTRACT: Nanoparticle-based radio-enhancement has the potential to improve cancer cell
eradication by augmenting the photoelectric cross-section of targeted cancer cells relative to the
healthy surroundings. Encouraging results have been reported for various nanomaterials, including
gold and hafnia. However, the lack of scalable synthesis methods and comparative studies is
prohibitive to rationalized material design and hampers translation of this promising cancer
management strategy. Here, we present a scalable (>100 g day−1) and sterile alternative to
conventional batch synthesis of group IV metal oxides (TiO2, ZrO2, and HfO2), which yields near-
monodisperse ultrasmall metal oxide nanoparticles with radio-enhancement properties. Access to group IV oxide nanoparticles,
which solely differ in atomic number but otherwise exhibit comparable morphologies, sizes, and surface chemistries, enables the
direct comparison of their radio-enhancement properties to rationally guide material selection for optimal radio-enhancement
performance. We show that the metal oxide nanoparticles exhibit atomic-number-dependent radio-enhancement in cancer cells
(HT1080 and HeLa), which is attenuated to baseline levels in normal fibroblasts (normal human dermal fibroblasts). The observed
radio-enhancement effects show excellent agreement with physical dose enhancement and nanoparticle dosimetry calculations.
Direct benchmarking against gold nanoparticles, the current gold standard in the field, rationalizes the use of hafnia nanoparticles
based on their radio-enhancement performance, which is superior to equi-sized gold nanoparticles. Taken together, the competitive
radio-enhancement properties for near-monodisperse nanoparticles produced by scalable and sterile flame spray synthesis offer a
route to overcoming key roadblocks in the translation of nanoparticle-based radio-enhancers.
Radiation therapy is an integral component in themanagement of patients affected by cancer. Due to the
associated short- and long-term damage caused by ionizing
radiation, the maximum radiation dose that can safely be
applied is limited.1 One of the main challenges of radiation
therapy is the delivery of an effective dose that can eradicate
the tumor while sparing the surrounding normal tissue.2
Most commonly, external high-energy beams are targeted to
the location of the tumor and deposit energy in the tissue while
passing through.3 To achieve the highest possible loco-regional
control of the dose with lower toxicities, advanced treatment
modes using intensity-modulated beams and complex beam
arrangements have been developed.4 Compared with conven-
tional, uniform beam-based radiotherapy, intensity-modulated
radiotherapy is more prone to marginal misses and is
associated with increased “beam-on” times,1 total body
exposure and radiation scattering, and leakage that might
cause secondary malignancies.4 New strategies are needed to
mitigate such radiation-induced negative side effects and to
further optimize the effectiveness of radiotherapy.3 In this
context, modifications that allow the application of lower
radiation doses for eradication of cancerous cells are
particularly sought after.
Tissue-specific application of substances with radio-sensitiz-
ing properties that enhance the therapeutic window and
outcome of radiotherapy is a highly appealing strategy.3,5 The
radio-sensitization properties of small molecule chemother-
apeutic drugs such as cisplatin have been harnessed in the
clinic for decades,6 but their inherent cytotoxicity requires
careful dose adjustment and limits the therapeutic window.6
Concurrent chemo-radiotherapy using traditional and new
generation drugs could be leveraged to enhance the sensitivity
of cancer cells to radiation while displaying non-overlapping
toxicities.7 Alternatively, nanoparticles consisting of elements
with high atomic number (Z) have been used to increase the
X-ray absorption cross section of tumor tissues compared with
their healthy surroundings.8 For photon energies (E) at which
the photoelectric effect is dominant, the absorption cross
section scales approximately with Z4E−3, building a physical
rationale for the use of high-Z nanoparticles.9 Interestingly,
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radio-enhancement effects have been observed for nano-
particles with atomic numbers ranging from low (such as Al,
Si, Ca, Ti, Fe, Cu, Zn, and Zr) to high (such as Ag, Gd, Hf, Pt,
Au, and Bi).10 Hence, the mode of action and the resulting
radio-sensitization of nanoparticle-based radio-enhancement
are much more complex than predicted solely based on
absorption cross-section phenomena.11 Dose enhancement has
been shown to be a combination of physical (secondary
particle generation and release),9 chemical (reactive oxygen
species concentration effects),12 and biological (molecular,
cellular, and/or tissue level effects)5 responses.13 The
disentangling of these processes and their contributions to
the observed radio-enhancement effects remains challenging
and is an active field of research.11 Nonetheless, increasing
experimental and clinical evidence exists in support of
nanoparticle-based radiotherapy enhancement in terms of
safety and efficacy.8,13−16 Apart from gold nanoparticles, which
have been widely explored in a vast range of research settings,
more exotic materials such as hafnium dioxide (HfO2) have
also successfully completed clinical phase II/III studies.16 In
fact, the 50 nm sized HfO2 nanoparticles synthesized by
precipitation have been marketed by Nanobiotix as NBTXR3/
Hensify and received the European CE Mark approval in April
of 2019 for the treatment of locally advanced soft tissue
sarcoma via intratumoral injection.17
Despite considerable excitement in the field,18 several
barriers continue to hamper clinical translation19 and more
widespread adoption of other nanoparticle radio-enhancers.20
These barriers include challenges related to scalable
manufacturing of high-quality nanoparticles with a narrow
size distribution and high colloidal stability.21 Additionally,
comparative studies of the performance of different nano-
particle radio-sensitizers in comparable settings are scarce.
Available experimental studies have investigated the effect of
nanoparticle size or surface functionalization but rarely address
the choice of core material, thus limiting understanding of the
factors (such as core material choice) that govern the
nanoparticle radio-enhancement efficiencies.10,13,20 For such
comparative studies, nanoparticles with comparable physico-
chemical properties are needed. However, the scalable
production of high-quality, crystalline, uniformly sized, and
small (<100 nm) nanoparticles poses a major translational
barrier due to significant synthetic challenges. Although
bottom-up wet chemical approaches offer good control over
nanoparticle size, shape, crystallinity, and compositions,22 even
at low temperatures,23 synthesis can be time-consuming (from
several hours to several days) and is typically performed in
batch mode.22 In contrast, flame spray pyrolysis (FSP) is a
scalable, continuous process with production rates of up to 1
kg h−124,25 and is also highly versatile,26 enabling the
Figure 1. Schematic of the benzyl alcohol synthesis (WetChem, (A)) and flame spray pyrolysis (FSP, (B)). High-resolution transmission electron
micrographs of TiO2 (yellow), ZrO2 (purple), and HfO2 (orange) nanoparticles produced by either WetChem synthesis (i−iii) or FSP synthesis
(iv−vi), respectively; scale bars are 4 nm. Transmission electron micrographs (TEM) and corresponding primary particle size distributions for
TiO2, ZrO2, and HfO2 nanoparticles produced by either WetChem synthesis (C−E) or FSP synthesis (F−H).
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reproducible synthesis of a diversity of metal, metal oxide, and
multicomponent nanoparticles of almost any composition from
relatively inexpensive precursors and solvents.27−29 Further-
more, compared with wet chemical processes, no solvent-
intensive workup is necessary.30 Despite the appealing
properties of FSP for scalable and sterile high-temperature
production of nanoparticles, the adoption of this process for
production of nanoparticles intended for biomedical applica-
tions is challenging.21 Nanoparticle products are collected in
the dry state, which is considered a critical drawback due to its
adverse effect on nanoparticle redispersibility.31−33 Addition-
ally, the process-intrinsic characteristic log-normal size
distribution34−36 is considered a potential drawback that
impacts the quality and safety of the product for biomedical
applications.37
In this work, we present the scalable synthesis of ultrasmall
group IV metal oxide nanoparticle radio-enhancers. Ultrasmall,
near-monodisperse group IV metal oxide nanoparticles were
prepared either by the well-established non-aqueous wet
chemical route38 in batch mode or by scalable flame aerosol
technology.23 We quantitatively assess the radio-enhancement
performance of the different nanoparticles in cancer cell lines
with different radio-sensitivities (HT1080 and HeLa) and in
fibroblasts (normal human dermal fibroblasts, NHDF) as a
function of colloidal stability, uptake, and intracellular
distribution. We quantify the impact of uptake and material
characteristics on the radio-enhancement properties of the
metal oxide nanoparticles, benchmark their efficiency against
gold nanoparticles, and hence pave the way to rationalized
materials selection optimized for radio-enhancement perform-
ance.
■ RESULTS AND DISCUSSION
Figure 1 shows the transmission electron microscopy (TEM)
images and size distributions for the produced metal oxide
nanoparticles. The nanoparticles synthesized by the wet
chemical, surfactant-free, non-aqueous sol−gel route38 (de-
noted as WetChem hereafter) consistently showed an elliptic
morphology with mean aspect ratios near 1.5 and comparable
primary particle sizes of 4.5 ± 0.9 nm for TiO2, 4.0 ± 0.4 nm
for ZrO2, and 5.7 ± 1.8 nm for HfO2 (averaged major and
minor axis, d̅TEM, Table 1). Although the sizes were generally
normally distributed with narrow standard deviations (SD),
HfO2 nanoparticles exhibited a higher degree of variation with
a log-normal size distribution along the major axis (Figure 1E).
The elliptical shape suggests a dominant growth direction
along the major axis. The characteristics of the WetChem-
synthesized nanoparticle are in excellent agreement with




41−43 nanoparticles. Nanoparticles synthesized by FSP
showed primary particle sizes in the same size range, centered
around 5.3 ± 1.7 nm for TiO2, 5.1 ± 1.6 nm for ZrO2, and 5.2
± 1.7 nm for HfO2 (d̅TEM). In contrast to the WetChem
nanoparticles, these nanoparticles were near-spherical in shape
with aspect ratios of approximately 1.15 and process-intrinsic
log-normal size distributions.26,34−36,44
The lattice fringes observed in high-resolution (HR)TEM
micrographs (Figure 1i−vi and Table S1 in the Supporting
Information) indicated that all as-prepared WetChem and FSP
nanoparticles were highly crystalline. X-ray diffraction analysis
of the as-prepared nanoparticles showed good agreement
between the crystallite diameters (dXRD, Table 1) and the
observed primary particle sizes in TEM. The dominant crystal
phases were tetragonal for TiO2 (in anatase mineral form) and
ZrO2 and monoclinic for HfO2 nanoparticles. Coexistence of a
second phase was detected in certain cases. The ZrO2
WetChem nanoparticles showed an additional monoclinic
phase (≈20%, based on Rietveld refinement). The occurrence
of mixed phases is well documented for ZrO2 synthesized via
the benzyl alcohol route.45 The phase composition and purity
are highly dependent on precursor selection and concentration
and temperature.46 The HfO2 FSP nanoparticles comprised a
second metastable47 orthorhombic phase (≈25%), in addition
to the thermodynamically more stable monoclinic phase.
Analysis of three independent particle batches confirmed a
high reproducibility of both production methods. The XRD
patterns coincide (Supporting Information, Figure S1), and
mean crystallite size analysis showed relative deviations
Table 1. Size Comparison of All Metal Oxide NPs Produced by WetChem- and FSP-Synthesized NPs Using Different
Methodsa
ad̅TEM: averaged minor and major axis from TEM images (mean ± SD). dXRD: refined crystallite sizes based on (1,1,1) (monoclinic and
orthorhombic) and (1,0,1) (tetragonal) peaks (size ± SD). SSA and dBET: specific surface area (SSA) and calculated size from nitrogen absorption
(BET) measurements. dDLS and DN(50): hydrodynamic size or z-average (intensity distribution, dDLS) and the median of the number distribution
(DN(50)) from DLS measurements, respectively (mean ± SD).
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between 1 and 8% for WetChem nanoparticles and between 3
and 6% for FSP-derived metal oxides (Supporting Information,
Table S2). All XRD patterns showed characteristic peak
broadening due to the small crystallite sizes.48,49 Rietveld
refinement analysis for FSP TiO2 and ZrO2 nanoparticles can
be found in the Supporting Information (Figure S2). The sizes
based on N2-adsorption (dBET) were in excellent agreement
with the primary particle sizes determined based on XRD and
TEM data (Table 1), indicating minor aggregation.50 Only the
WetChem TiO2 and ZrO2 nanoparticles showed a slight
discrepancy between dBET and the primary particle size
estimates based on crystallite (dXRD) or microscopy sizes
(d̅TEM).
The WetChem route applied in this work constitutes a
robust procedure for the synthesis of high-quality sub-10 nm
crystalline metal oxide nanoparticles at temperatures below
250 °C.23 It is, however, considerably more time- and labor-
intensive than the FSP route. The aging times needed to form
crystalline nanoparticles with a size below 10 nm via halide (or
alternative) elimination have been reported to range from
hours to several days for TiO2 (depending on reaction
temperature),51 2−3 days for ZrO2,39,40 and 2−4 days for
HfO2
41−43 nanoparticles. Generally, increasing the reaction
times during production of metal oxide nanoparticles via the
benzyl alcohol route results in a moderate growth of the
primary particles (based on XRD crystal size).22,51,52 This
process is exemplarily shown for the case of WetChem ZrO2
nanoparticles in which an increase in reaction time from 3 to
72 h led to crystal growth from 2 to 4 nm for the more
dominant tetragonal crystal phase (Supporting Information,
Figure S3). Additionally, Niederberger et al.51 observed
moderate crystal growth for benzyl alcohol-made TiO2
nanoparticles. Alternatively, less time-consuming wet chem-
istry-based protocols have been previously investigated for the
production53 of HfO2 but have failed to yield redispersible
colloidally stable nanoparticle systems due to high temperature
synthesis or post-processing. Although FSP synthesis is a high-
temperature process in which nanoparticles are collected in the
dry state, it showed primary particle quality comparable to that
of WetChem synthesis.
The small primary particle size in our FSP synthesis is a
result of the low molarity and low precursor-to-oxygen flow
rate ratio.27,30 Monoclinic and tetragonal ZrO2 nanoparticles
were reported by Mueller et al.,24 who showed control over the
particle diameter from 6 to 35 nm as a function of production
rates (50−600 g h−1), precursor compositions, and dispersion
gas flow rates. FSP offers a robust route to sterile and scalable
synthesis of ultrasmall group IV metal oxide nanoparticles;
however, ideal precursors (alkoxides and organometallic
compounds) are more expensive than nitrate precursors,
which usually give inhomogeneous particles. Furthermore,
not all precursors are easily miscible, explosive precursor
mixtures and conditions should be avoided, and under certain
conditions, products of incomplete combustion could be
present.30
Therefore, organic contents of nanoparticles were quantified
by thermogravimetric analysis (TGA) for as-prepared nano-
particles (FSP) and after workup and dialysis (WetChem). A
minimal content of potentially harmful organic remnants on
the nanoparticle surface (physically adsorbed or chemically
bonded) after synthesis is highly favorable because it reduces
the need for costly post-processing workup and reduces solvent
use.
The organic contents remained well below 6 wt % for both
synthesis routes (Figure 2A,B). For example, both HfO2
nanoparticles showed a slight mass decrease (≈0.5 wt %) in
the temperature range between 110 and 300 °C, which is
attributed to the loss of physically adsorbed water or light
organic molecules.40,43 This initial mass decrease is followed by
a stepwise mass loss between 300 and 600 °C, amounting to
0.5 wt % for FSP HfO2 and 1.7 wt % for WetChem HfO2,
which is assigned to the desorption of chemically bonded
organic surface remnants (see also the derivative thermogravi-
metric curve, DTG; Supporting Information, Figure S4).40 For
the other oxides, the physisorbed organic residues were
approximately 1−3 wt % for ZrO2 and 3−4 wt % for TiO2
nanoparticles. The chemisorbed organic surface remnants were
estimated as 3.0 wt % (WetChem) and 1.5 wt % (FSP) for
ZrO2 nanoparticles and as 1.3 wt % (WetChem) and 1.5 wt %
(FSP) for TiO2 nanoparticles. Generally, the nanoparticles
synthesized in the flame showed lower amounts of organic
residues than the WetChem nanoparticles.
For the WetChem nanoparticles, washing steps were
necessary to remove excess solvents and loosely attached
organic residues for successful transfer of the nanoparticles into
water. Except for ZrO2, the transfer of WetChem nanoparticles
to water resulted in de-agglomerated near-transparent
dispersions, even at concentrations >5 mg mL−1. The high
water dispersibility in those systems might stem from chloride
and benzyl group terminated surfaces.54,55 The nanoparticle
Figure 2. Thermogravimetric analysis (TGA; A, B), hydrodynamic size distributions obtained by DLS (C, D), and surface charge (zeta potential; E,
F) in water of WetChem (top) and FSP-synthesized (bottom) metal oxide NPs.
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number medians were 5 (HfO2) and 11 nm (TiO2),
respectively, indicating minor agglomeration (Table 1 and
Figure 2C). Despite extensive washing, the agglomerate sizes
of ZrO2 in water could not be decreased, and the mean
number size (around 145 nm) remained considerably higher
compared with the other oxides (Table 1 and Figure 2C).
Additional surface modification might be used to reduce
agglomeration in polar solvents, as shown by Kockmann et al.56
Nanoparticles synthesized by FSP were readily water-
dispersible directly after synthesis, and no workup was
required. The hydrodynamic sizes (dDLS) of these particles
were similar to each other, and their number medians
(DN(50)) were near 30 nm, indicating minor agglomeration
in water and cell culture medium (Table 1, Figure 2D, and
Figures S4 and S5 in the Supporting Information). Metal oxide
nanoparticles made in flame reactors are typically hydrophilic
as they have a high surface density of hydroxyl groups57−59 and
hence disperse well in aqueous media. Note that the
discrepancy between d̅TEM and dDLS originates from partial
agglomeration, the difference between intensity (DLS) and
number-based (TEM) distribution as well as overestimation of
the average hydrodynamic size of fractal-like nanoparticles by
DLS.60 Colloidal stability and sedimentation measurements
performed using the method described by Spyrogianni et al.61
confirm the high colloidal stability of WetChem TiO2 and
HfO2. These measurements further indicate that the
sedimentation behavior of all FSP nanoparticles is highly
similar and comparable to that observed for 50 nm gold
nanoparticles (Supporting Information, Figures S6 and S7).
These findings are well in line also with agglomerate sizes
observed for air-dried nanoparticle suspensions in TEM
(Supporting Information, Figure S8). Zeta potential values
measured in 2% PBS were consistently negative (range
between −33 and −37 mV, Figure 2E,F) and minimally
affected by the type of oxide or the synthesis route. Taken
together, the WetChem-synthesized oxides showed differences
in colloidal behavior. HfO2 and TiO2 nanoparticles were highly
dispersible and colloidally stable, whereas ZrO2 nanoparticles
showed significant agglomeration. The different FSP-synthe-
sized oxide nanoparticles exhibited comparable physicochem-
ical characteristics and high water dispersibility with only
minor agglomeration. The above results indicate that although
gram-scale batches of high-quality group IV metal oxides are
achievable via the benzyl alcohol route,39,51,62 continuous flow
processing,22,63 including flame spray pyrolysis, offers a
promising strategy for increasing the production rates (mg or
g day−1) to pilot-plant scales (kg day−1)63 with uncompro-
mised product quality.
Following physicochemical characterization of the as-
prepared nanoparticles, their toxicity (in the absence of
radiation) was investigated against different cell types,
including dermal fibroblasts (NHDF), fibrosarcoma cells
(HT1080), and the widely researched HeLa cells (adenocarci-
noma). The HT1080 and HeLa cell lines were selected as well-
established cancer cell lines with relatively high radio-
resistance.64,65 Primary fibroblasts were chosen as representa-
tive noncancerous cells. Luminescent ATP quantification
(indicating metabolically active cells) and lactate dehydrogen-
ase (LDH) release (indicating membrane damage) were
selected as sensitive endpoints to assess the nanoparticle
effects on cell viability and to determine a subtoxic nano-
particle dose for radio-enhancement experiments. The results
are shown in Figure 3A−D for HT1080 and Figures S9 and
S10 for HeLa and NHDF, respectively. The two assays showed
excellent agreement and revealed only minor effects on cell
viability for nanoparticle concentrations up to 1 mg per mL
(equivalent to a total applied dose of 10 ng per seeded cell)
(Figure 3A−D). Only the WetChem ZrO2 nanoparticles
showed a detectable effect on the cell viability of HT1080 cells
Figure 3. Cytotoxicity (lactate dehydrogenase release (LDH); A, B), cell viability (luminescence showing metabolic activity; C, D), and in vitro
sedimentation calculations (E, F) following 24 h incubation of fibrosarcoma cells (HT1080) with WetChem-synthesized (A, C, E) and FSP-
synthesized (B, D, F) group IV metal oxide NPs. The corresponding total NP mass per seeded cell (ng cell−1) is shown next to the administered
NP incubation concentration (mg mL−1). In A−D, the gray horizontal bar shows the mean ± SD values of the cells of the negative control
(untreated). Results are from N ≥ 2 independent biological experiments, and error bars are calculated using Gaussian error propagation.
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(Figure 3) but not on the other two cell lines (Supporting
Information, Figure S9 (HeLa) and Figure S10 (NHDF)).
The effect on HT1080 cell viability might at least partially be
explained by the higher hydrodynamic size of WetChem ZrO2
and thus faster sedimentation,66 resulting in higher cellular
uptake (vide inf ra for results on cellular uptake).61 To confirm
this hypothesis, nanoparticle sedimentation and diffusion were
calculated using the modified distorted grid model.67
Considering the average hydrodynamic size of particles in
the cell medium, the bottom concentration (lowest 10 μm of a
well) was estimated to be at least five times higher for
WetChem ZrO2 than for the other oxide nanoparticles (Figure
3E,F). The higher tolerance by HeLa and NHDF cells
illustrates the varying uptake (Figure 4 and Figure S11 in
the Supporting Information) and susceptibility of different cell
lines to nanoparticle effects (Figure 3 and Figures S9 and S10
in the Supporting Information). Based on the above
cytotoxicity and cell viability studies, two subtoxic adminis-
tered total doses normalized to cell seeding number, i.e., 1 and
5 ng per seeded cell, were selected for further studies.
After confirming the cytocompatibility of the selected
nanoparticle doses, the nanoparticle uptake and intracellular
distribution were investigated in HT1080 (Figure 4), HeLa
and NHDF (Supporting Information, Figure S11) cells by
inductively coupled plasma mass spectroscopy (ICP-MS) and
(scanning) transmission electron microscopy. As evident from
the scanning transmission micrographs, uptake measurements
include intracellular nanoparticles as well as those firmly
attached to the outer cellular membrane (Figure 4). For the
FSP nanoparticles, mass uptake was comparable for the
different oxides, reaching values of approximately 0.1 ng
cell−1 for the lower administered dose and approximately 0.3
ng cell−1 for the higher administered dose (Figure 4A). The
nanoparticle mass uptake was also converted into nanoparticle
number concentration per cell, with estimated cell uptakes of
81 × 107, 71 × 107, and 54 × 107 nanoparticles for the TiO2,
ZrO2, and HfO2 FSP nanoparticles, respectively. Although the
cellular mass uptake was very comparable for the FSP
nanoparticles (6% deviation in the high dose), greater
variations were observed for the WetChem nanoparticles.
Expectedly and well in line with the large hydrodynamic size
and the dosimetry calculations (Supporting Information,
Figure S5), the highest uptake was observed for the WetChem
ZrO2 nanoparticles. Interestingly, elemental analysis showed
that compared with all oxides, the citrate-stabilized 5 nm gold
nanoparticles showed lower cell uptakes of 0.01 and 0.1 ng
cell−1 (<1% of total, Figure 4A), despite the fact that dosimetry
calculations show similar mass concentrations at the bottom of
the well for gold and metal oxides. Larger gold nanoparticles,
namely, 50 and 150 nm, were internalized more readily and to
an extent comparable to the FSP metal oxide nanoparticles.
The uptake results are in good agreement with previous studies
in a similar setting68 and in line with literature for other cell
lines at comparable nanoparticle administration concentrations
(Supporting Information, Table S3). The lower uptake for 5
nm gold nanoparticles was also observed in the scanning
Figure 4. Mass uptake quantification (ICP-MS) of FSP- and WetChem-synthesized metal oxide and Au NPs (5, 50, and 150 nm) in HT1080
fibrosarcoma cells for two different administered NP doses (low: 1 ng cell−1, high: 5 ng cell−1) after 24 h of NP incubation (A). Right y-axis denotes
the mass equivalent estimated number of NPs with 5 nm size. Black arrows show correspondence to only the left y-axis. Representative scanning
transmission electron micrographs of HT1080 cells showing intracellular WetChem HfO2 (B) and Au NPs (C). Intracellular NP agglomerate size
(Feret diameter) estimated based on STEM images (D) for the different types of NPs. Boxes range from the 25th to 75th percentile and include
the median (black bars) and mean (green diamonds). Whiskers extend to the most extreme values not considered outliers. Red crosses denote
outliers.
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transmission electron micrographs (Figure 4C). From the
STEM images, it can also be observed that intracellular
nanoparticle agglomerates were formed (Figure 4B,C and
Figure S12 in the Supporting Information). The intracellular
agglomerate characteristics were quantified and showed an
average Feret diameter in the range between 0.4 and 0.5 μm,
regardless of the type of metal/metal oxide or synthesis route,
which is in good agreement with previous work on gold
nanoparticles69 (Figure 4D and Figure S12 in the Supporting
Information).
It was also observed that these agglomerates can cluster
together to form large nanoparticle assemblies well above the
size of 1 μm (Figure 4B,D). The nanoparticle uptake estimated
based on STEM image analysis relating the intracellular
nanoparticle area to the cell area shows trends in line with the
ICP-MS measurements (Supporting Information, Figure S13).
Taken together, the similar physicochemical and water
dispersibility characteristics of the FSP-synthesized metal
oxides led to a comparable mass uptake into cells, which
allows direct comparison of their radio-enhancement efficacies.
In contrast, the WetChem nanoparticles showed a more
variable uptake that scaled with their colloidal size and stability,
i.e., low uptake for small and stable (TiO2 and HfO2)
nanoparticles and high uptake for agglomerated, rapidly
sedimenting (ZrO2) nanoparticles.
Following comprehensive physicochemical characterization
of the nanoparticles and the cellular uptake, the radio-
sensitization effects were assessed in a well-standardized ex
vivo setup using a tissue phantom and relatively radio-resistant
sarcoma cells (HT1080), cervical adenocarcinoma cells
(HeLa), and normal fibroblasts (NHDF). The radio-
sensitization effects of WetChem- and FSP-synthesized
nanoparticles were assessed under comparable conditions
and benchmarked against equi-dosed 5 nm Au nanoparticles.
We note that 24 h incubation of cells with nanoparticles led to
a viability after 7 days (long-term effect) that was comparable
to that of nanoparticle-free control cells, indicating no
damaging effect of nanoparticles in the absence of radiation
(Supporting Information, Figures S14 and S15). Only the high
ZrO2 WetChem nanoparticle concentration showed a
Figure 5. HT1080 cell survival fraction as a function of irradiation dose (Gy) of 150 kVp X-rays with or without prior incubation with low or high
NP doses (low: 1 ng cell−1; high: 5 ng cell−1) of different metal oxides and 5 nm gold NPs for 24 h. Lines through data show linear quadratic
survival curve fits for low (dashed) and high (solid) NP concentrations. Left: WetChem-synthesized NPs. Right: FSP-synthesized NPs. Results
shown as mean ± SD (n = 3).
Figure 6. Dose enhancement efficiencies for different NPs. Physical dose enhancement as total energy emitted from a single 20 nm Ti, Zr, or Hf
NP and its contributions from secondary electrons (Auger, photo, and Compton electrons) and photons following an ionizing event (Monte Carlo
simulation data obtained from McMahon et al.73) (A). Mean dose modifying ratio (N = 2) and linear correlation with uptake of the different group
IV oxide NPs (WetChem and FSP TiO2, ZrO2, and HfO2) and 5 nm Au NPs (B); bold dashed lines show linear fit with R
2 = 0.85 (HfO2), R
2 =
0.97 (ZrO2), and R
2 = 0.59 (TiO2); thin dashed lines show best linear fit for lowest and highest TiO2 NP uptakes. Fitted dose enhancement
efficiencies per NP, ηNP, irrespective of the synthesis method (C). DMR50% of 5 nm Au NPs could not be computed due to nonlinearity (indicated
by an asterisk). Experimentally observed dose enhancement as a function of metal mass per cell (D). Shaded areas in (B) and (D) are visual aids
showing the NP effectiveness area.
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significantly decreased long-term cell viability and was
excluded from further analysis.
With irradiation, the viability of the HT1080 cells expectedly
decreased in a dose-dependent linear quadratic fashion (Figure
5). Approximately 80% of control cells (no nanoparticle
treatment) survived an irradiation dose of 6 Gy. The D50%
value, indicating the irradiation dose that kills 50% of the cells,
was around 9 Gy. With nanoparticles, the D50% decreased as a
function of increasing nanoparticle concentration and increas-
ing atomic number. Experiments showed a clear trend of the
D50% (TiO2 > ZrO2 > HfO2) following the inverse sequence of
atomic number (Ti(Z = 22) < Zr(Z = 40) < Hf(Z = 72)) for
both low and high nanoparticle concentrations (Supporting
Information, Table S4). The only exception is WetChem ZrO2
nanoparticles, which show a lower D50% than HfO2 due to their
larger hydrodynamic size resulting in higher uptake. Radio-
enhancement quantification can be expressed as the dose
modifying ratio (DMR) by dividing the irradiation D50% of the






= .70 Hence, the DMR50% was following the
order of the atomic number (HfO2 > ZrO2 > TiO2) for the
metal oxides. The 5 nm sized gold nanoparticles performed
similarly to 5 nm sized TiO2 nanoparticles in the current
setting (Supporting Information, Table S4). This result is likely
attributable, at least in part, to the reduced cellular uptake of
the gold compared with the group IV metal oxide nano-
particles. For comparison, we performed additional radio-
enhancement experiments using 50 and 150 nm gold
nanoparticles (Supporting Information, Figure S16). Higher
uptake and higher DMR50% values were observed for 50 and
150 nm than for 5 nm gold nanoparticles; however, dose
enhancement effects were very similar to those for 5 nm HfO2
at the same mass uptake.
At comparable uptake, the dose enhancement increases with
the nanoparticle atomic number, suggesting that the observed
effects are, at least in part caused by the different mass
attenuation cross-sections and secondary particle emissions,
next to chemical and biological enhancements mechanisms.
Figure 6A shows a comparison of the total energy emitted
from a nanoparticle following an ionizing event as calculated
based on Monte Carlo simulations55 for the different types of
nanoparticles. Following an ionization event on the surface of a
Hf, Zr, Ti, or Au nanoparticle, secondary electrons (such as
photo and Auger electrons) and fluorescent photons are
created, delivering a high dose locally. This physical dose
enhancement (based on the total energy emission from a
nanoparticle) suggests that hafnium-based particles could be
more effective than zirconium-based particles followed by
titanium-based particles. We calculated the biological effective-
ness of our nanoparticles in terms of DMR, which is a concept
Figure 7. Radio-enhancement effects (DMR50%) of WetChem-produced and FSP-produced metal oxide NPs and Au NPs for two cancer cell lines
(HT1080 (A) and HeLa (B)) and one noncancerous cell line (NHDF (C)). Results are given for two different administered NP doses (low: 1 ng
cell−1, high: 5 ng cell−1). Results are derived as mean ± SD from at least N = 2 independent biological experiments (only in the case of Au 50 and
150 nm, N = 1) and corresponding linear quadratic survival curve fits. Asterisk: viability < 80% for sham (0 Gy) irradiation observed compared with
NP free control cells.:1 Data for 50 nm Au NPs in HeLa and NHDF cells extracted from Neuer et al.68 for a comparable setting.
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where DX is the dose of X-ray radiation and DI is the dose of
densely ionizing radiation leading to the same cell-killing
level).71 From a physical point of view, the RBE for
nanoparticles scales linearly with their concentration in the
tumor cells.71,72 Correspondingly, our metal oxide nanoparticle
DMRs, irrespective of the synthesis method, were analytically
described by a linear function: DMRNP = 1 + ηNP#NP, where
ηNP is the nanoparticle dose enhancement efficiency and #NP is
the intracellular and the cell membrane-attached number of
TiO2, ZrO2, or HfO2 nanoparticles (Figure 6B). From this
result, it can be observed that the HfO2 and ZrO2
nanoparticles are approximately four and two times more
effective than TiO2 nanoparticles, respectively, mirroring the
ratios from the energy emission predictions per nanoparticle
(Figure 6C). When DMRs are expressed as a function of metal
mass per cell, highest DMRs are observed for HfO2 and the 50
and 150 nm sized Au nanoparticles (Figure 6D). While the
uptake was very similar for all FSP-made nanoparticles, hence
allowing direct comparison of the DMR values at comparable
uptake, comparison with WetChem and gold nanoparticles at
the exact same uptake is more challenging. Nonetheless, since
DMR values show a linear dependence on uptake, Figure 6B,D
provides important insights on performance for the different
nanoparticles at comparable number and mass concentrations,
respectively.
Analogous to the HT1080 cells, nanoparticle dose- and
atomic number-dependent radio-enhancement effects were
also found in HeLa (adenocarcinoma) cells, although with an
overall lower effect (Figure 7 and Figure S17 in the Supporting
Information). Varying dose modifying ratios between different
cell lines for the same nanoparticles are not surprising because
radio-sensitization effects have been shown to be strongly cell
line-dependent.74,75 While the DMRs correlate linearly with
uptake in a certain cell line, the values still vary widely between
cell lines. In fibroblasts (NHDF), no significant radio-
sensitization effect was found (DMRs near 1). This might be
caused by the lower uptake (of the metal oxide nanoparticles,
see Figure S11 in the Supporting Information) and/or higher
tolerance to ROS76 compared with tumor cells. No long-term
effect on cell viability was observed in HeLa and NHDF cells
in the absence of radiation, not even for WetChem ZrO2,
indicating that both radio-enhancement properties and
cytotoxicity are strongly dependent on cell line (Supporting
Information, Figures S14 and S15). A summary of all survival
fractions for different cell lines can be found in Figure S18 in
the Supporting Information. Overall, in the two cancer cell
lines, the DMRs were highest for HfO2 and Au 50 and 150 nm
followed by ZrO2 and TiO2 nanoparticles. The FSP-
synthesized nanoparticles showed higher DMRs than the
WetChem-synthesized nanoparticles, which is in line with the
observed higher nanoparticle uptake. The biological effects of
the different crystal phases and their influence on cytotoxicity
and radio-enhancement properties remain to be investigated
using phase pure nanoparticles.
A comparison of the observed effects with the literature is
challenging due to the various methodologies reported, which
further highlights the need for comparative studies that directly
compare different nanomaterials in the same experiment.
Youkhana et al.77 found nanoparticle concentration-dependent
DMRs between 1.2 and 1.7 for 30 nm amine-functionalized
TiO2 nanoparticles at 80 kVp X-rays. In contrast, for 0.5 mM
TiO2 nanoparticles, DMRs of 1.21 and 1.27 were found for
HaCaT and DU145 cells, respectively. Our results show similar
DMRs of 1.3 and 1.4 in HT1080 cells using a slightly lower
concentration of 0.42 mM for WetChem and FSP TiO2
nanoparticles, respectively.
For the most researched Au nanoparticles, literature values
for these particles in the same cell lines (HT1080 and HeLa)
can be found. Joh et al. found a DMR of 1.16 for 1 mM 12 nm
core pegylated Au nanoparticles in clonogenic HT1080 cell
survival assays (150 kVp).78 For HeLa cells, Chithrani et al.
found a DMR of 1.2 (220 kVp) for 14 nm nanoparticles with
an uptake of ∼0.0001 ng cell−1.69 These values are comparable
to our findings for 5 nm Au nanoparticles in HeLa (DMR 1.23
with 0.004 ng cell−1) and HT1080 cells (DMRs 1.28 and 1.37
for 0.01 and 0.1 ng cell−1, Figure 7A,B). Although we used a
metabolic assay instead of a clonogenic assay, there is evidence
that the conclusions drawn from both assays are concord-
ant.13,77,79 We further confirmed in a small-scale experiment
that both assays are in line with each other (Supporting
Information, Figure S19).
Nonlinearity has been observed for 5 nm Au nanoparticles
(Figure 6C), where a nanoparticle dose exceeding 5 ng cell−1
led to higher uptake (2×) and cytotoxicity without additional
dose enhancement (Supporting Information, Figure S16).
These findings are in good agreement with Zhang et al.80
reporting higher toxicity for 4.8 nm Au nanoparticles and lower
dose enhancement with increasing concentration compared to
larger nanoparticles. Similarly, Liu et al. reported a nonlinear
dependence of the radio-enhancement on the concentration
for 15 nm Au nanoparticles in HeLa cells.81 They proposed a
radio-sensitization mechanism based on the production of
hydroxyl radicals and showed a decreased ROS production
with increasing nanoparticle concentration. For 50 nm sized
Au nanoparticles, Chithrani et al. found an uptake of ∼0.01 ng
cell−1 into HeLa cells with DMRs of 1.43 (220 kVp) and 1.66
(105 kVp). These values are well in line with the DMR of 1.5
(150 kVp) for 50 nm Au nanoparticles in HeLa cells and
comparable the ones for HfO2 (DMR FSP high 1.66 and
WetChem high 1.70, Figure 7B). Taken together, FSP-
synthesized hafnia nanoparticles outcompeted 5 nm Au
nanoparticles in radio-enhancement due to the higher uptake
and better cytocompatibility and performed comparably to 50
and 150 nm sized Au nanoparticles, hence rationalizing the
promising clinical results found for hafnia. Note that radio-
enhancement effects are, in addition to nanomaterial
composition, strongly dependent on additional factors. Cell
type, cell age, and nanoparticle suspension stability might
directly or indirectly (via altered uptake)82 influence radio-
enhancement effects, which should therefore always be
assessed as a function of nanoparticle uptake.
Importantly, the flame spray pyrolysis production process
can be readily scaled up without compromises in product
quality. While this study is the first to report the FSP synthesis
of HfO2, large-scale production of FSP-synthesized metal
oxides, including TiO2
83,84 and ZrO2,
24,85 has been achieved,
albeit with larger particle size. Typically, FSP-synthesized
particles are produced exhibiting larger primary particle sizes
(between 5 and 500 nm) than the ones reported here (size
distributions between 2 and 10 nm).86 Flame-synthesized TiO2
is also commercially available (e.g., P25, P90 by Degussa/
Evonik). To demonstrate scale-up of the synthesis of ultrasmall
group IV metal oxide nanoparticles as an important step in the
translation, we produced a large batch (50 g) of the best
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performing FSP nanoparticles (HfO2) at a production rate of
15 g h−1 and a yield of >82%. Particle characteristics are
primarily determined by the high-temperature particle
residence times,85 which have been selected here to yield
ultrasmall nanoparticles (around 5 nm). While we report the
first continuous FSP production of HfO2, similar and even
higher production (>100 g h−1) rates have been achieved in
flame spray pyrolysis pilot scale reactors for other oxides25,85
and larger particle sizes. Production rates could be further
increased in a straightforward manner by using multiple flames.
Most importantly, we also show that the nanoparticle
properties and radio-enhancement performance of the scaled-
up particles were no different from those of the small-scale
batch (Supporting Information, Figures S20 and S21). This
direct demonstration of scalability illustrates the feasibility for
large-scale production of ultrasmall group IV metal oxides
necessary for future clinical application.
■ CONCLUSIONS
Taken together, we present a route to the scalable and sterile
high-temperature production of ultrasmall, near-monodisperse,
water-dispersible metal oxide nanoparticles with radio-
enhancement activity. Flame spray pyrolysis enables scalable
production of high-quality nanoparticle radio-enhancers, hence
offering an attractive route to systematic investigations
advancing the rationalized design of nanoparticle-enhanced
radiotherapy agents. We further demonstrate in a direct
comparison of morphologically similar nanoparticles with
varying atomic number, that the radio-enhancement properties
at ortho-voltage energies are dominated by physical effects,
strongly depend on atomic number, and linearly depend on
nanoparticle uptake. The approach presented here offers a
route to rationalized material design and radio-enhancement
performance optimization in cellular systems, which allow
quantitative evaluation of the radio-enhancement performance
under well-controlled conditions. By rationalizing material
selection and providing a scalable and sterile route to the
manufacturing of these materials, the presented strategy is
foreseen to decisively contribute to the reduction of animal
experiments in accordance with the 3R principles.87 More
concretely, the direct comparison to gold supplies the rational
for further clinical exploration of hafnia nanoparticles, which
might be produced in the future via flame pyrolysis as a
scalable, sterile, cost-effective, and robust alternative to current
synthesis routes. This work provides important insights needed
to guide future developments in the field of nanoparticle radio-
enhancers and, most crucially, provides scientists with a
method to produce these materials at clinically relevant
qualities and scales.
■ EXPERIMENTAL SECTION
Wet Chemistry Synthesis. For synthesis of TiO2, ZrO2, and
HfO2 nanoparticles via the wet chemistry route, a surfactant free,
solvent-controlled nonhydrolytic sol−gel route was applied.23 The
methods of Buha et al.42 (HfO2), Garnweitner et al.
39 (ZrO2), and
Niederberger et al.51 (TiO2) were used with minor adaptions (see the
Supporting Information for detailed experimental procedures). After
synthesis, nanoparticles were dialyzed in ultrapure water for at least 2
days using dialysis membranes (Spectra/Por, Spectrum Labs) with an
MWCO of 6−8 kDa.
FSP Synthesis. Titania, zirconia, and hafnia nanoparticles were
produced by flame spray pyrolysis.27 Precursor solutions were
prepared by dissolving titanium isopropoxide (TTIP, >97%, Alfa
Aesar) or zirconyl 2-ethylehexanoate (in mineral spirits, ∼6% Zr,
STREM Chemicals) in xylene (>98.5%, Sigma Aldrich) at a metal
concentration of 0.16 M followed by magnetic stirring for 30 min. In
the case of hafnia, the precursor hafnium isopropoxide isopropanol
adduct (99%, Alfa Aesar) was first dissolved in 2-ethylhexanoic acid
(2-EHA, purity of 99%, Sigma-Aldrich) at 120 °C under reflux
overnight at a metal concentration of 0.96 M. This step was important
to achieve a homogeneous nanoparticle size distribution. After
cooling, the solution was diluted with five parts xylene to reach a
final metal concentration of 0.16 M. The precursor solutions were fed
at 3 mL min−1 through a thin capillary and dispersed into fine
droplets by 5 L min−1 oxygen (PanGAS, purity >99%) with a pressure
drop of 1.5 bar. The spray flame was sustained by a ring-shaped pilot
flame of premixed methane/oxygen fed at a ratio of 1.5/3.2 L min−1.
Particles were collected on a glass microfiber filter unit (Whatman
GF) connected to a gas pump (Busch Mink MM 1202 AV). After
collection from the filter, the nanoparticle powder was sieved (mesh
size = 250 μm) to remove the filter residues.
Preparation of Nanoparticle Suspensions. Wet chemistry-
produced nanoparticles were used after dialysis. The nanoparticle
concentration was determined by gravimetric analysis of the
suspensions. FSP-synthesized particle suspensions were prepared by
the addition of ultrapure water to a weighted amount of powder. All
nanoparticle suspensions were vortexed and bath sonicated prior to
use.
Gold Nanoparticles. Citrate-stabilized gold nanoparticles in
water (1 mg mL−1) with a nominal nanoparticle size of 5 ± 1 nm
or 50 ± 4 nm and a purity of 99.99% (“biopure”) were purchased
from nanoComposix (San Diego, US). Gold nanoparticles (150 nm)
in citrate buffer were purchased from Sigma-Aldrich (product number
742058) and upconcentrated by centrifugation to reach a final
concentration of 1 mg mL−1 before use.
Nanoparticle Characterization. Nanoparticles were character-
ized by X-ray diffraction (XRD), transmission electron microscopy
(TEM), thermogravimetric analysis (TGA), N2-adsorption (Bruna-
uer−Emmett−Teller (BET)), dynamic light scattering (DLS), and
zeta potential measurements. Full experimental details can be found in
the Supporting Information.
Cell Culture. Human fibrosarcoma HT1080 [HT1080] (ATCC
CCL121) and human cervical carcinoma HeLa (ATCC CRMCCL2)
cells were cultured in Minimum Essential Medium (MEM)
containing 10% fetal calf serum (FCS); 1% of L-glutamine,
penicillin−streptomycin−neomycin (PSN), and non-essential amino
acids (NEAA); and 1 mM sodium pyruvate. NHDF (PromoCell,
Germany) were cultured in Dulbecco’s Modified Eagle Medium
(DMEM) with 10% FCS and 1% PSN. All cells were cultured at 37
°C in a humidified atmosphere containing 5% CO2. The cells were
subcultured after growing to 60−80% confluency.
Cytotoxicity Assay. To evaluate the cytotoxicity of nanoparticles,
nanoparticle stock suspensions were prepared in ultrapure water at 5
and 1 mg mL−1 nanoparticle concentrations. An amount of 10,000
cells was seeded in a sterile black 96-well plate with a transparent
bottom in full cell culture medium (80 μL) and allowed to attach
overnight. Then, to reach the final particle concentration and 100 μL
total volume per well, the corresponding amounts of ultrapure water
(vehicle control) and freshly prepared nanoparticle suspensions were
added to the cells in quadruplicate (n = 4, technical replicates). The
resulting final particle concentrations ranged from 0 to 0.1, 0.25, 0.5,
and 1 mg mL−1. The total ultrapure water content per well was 20%.
After nanoparticle addition, the cells were incubated for 24 h at 37 °C
in a standard incubator. For the cytotoxicity assay, 50 μL of
supernatant of each well was transferred to a new 96-well plate, and
50 μL lactate dehydrogenase substrate (LDH, CytoTox 96 Non-
Radioactive Cytotoxicity Assay, Promega, G1780) was added. The
plates were incubated in the dark for 30 min at room temperature,
and the absorbance at 490 nm was measured using a Mithras LB 943
Multimode Plate Reader. To calculate LDH release, reader values
were first background subtracted (mean of three background values)
and subsequently normalized to the corresponding positive control.
Cell Viability Assay. To measure the viability of cells via ATP
content, the left-over supernatant in each well was aspirated, and 50
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μL of fresh full cell culture medium at room temperature was added to
each well. Then, CellTiter-Glo Reagent (CellTiter-Glo Luminescent
Cell Viability Assay, Promega, G7571) was added (1:1 volume) and
incubated for 10 min at room temperature on a shaker in the dark.
After another 20 min of incubation in the dark, the luminescence was
recorded with the plate reader. Analysis of the reader values was
performed by background subtraction and normalization to the
corresponding negative control (100% viable).
Elemental Analysis Using Inductively Coupled Plasma Mass
Spectrometry (ICP-MS). Prior to digestion, cell handling steps
identical to an irradiation experiment (vide inf ra) were performed. In
short, 2000 HT1080 cells per well were seeded in 290 μL cell medium
in 48-well plates. After overnight attachment, 10 μL of a 0 (control),
200, or 1000 ng μL−1 aqueous dispersion of metal oxide or gold
nanoparticles was added in triplicate. After 24 h, the nanoparticle-
containing supernatants were removed, and the cells were washed 2×
with PBS, trypsinized (80 μL), and covered again with culture
medium. The cell number (to quantify uptake per cell) was
determined by counting the cells from six pooled control wells
using a hemocytometer. The remaining cell samples were harvested
and stored at −20 °C for further analysis. Prior to ICP-MS analysis,
samples were digested using the following procedure. In a 50 mL
Falcon tube, 150 μL of sample was mixed with aqua regia (3 mL of
HCl + 1 mL of HNO3) and 1 mL of HF (only added in the case of
HfO2, ZrO2, and TiO2) and allowed to react at room temperature for
3 h or overnight (only in the case of Au). Subsequently, the visually
clear samples were filled to the mark (50 mL) with ultrapure water.
Prior to analysis, samples were diluted as necessary either in 2%
HNO3 (HfO2, ZrO2, and TiO2 nanoparticles) or 1% HCl (Au
nanoparticles).
Elemental analysis was performed using an Agilent 7900 ICP-MS
(Agilent Technologies, Santa Clara, US) instrument. To correct for
non-spectral interferences (i.e., physical/matrix effects), an internal
standard containing 100 ppb Sc, Ge, In, and Lu was mixed on-line
with the sample via a t-piece at a ratio of 1:10. All elements were
measured in He mode. Element concentrations in undiluted samples
were determined using matrix-matched calibration standards (i.e.,
spiked with cell medium matrix at the respective concentration). An
external quality control standard (IV100, Inorganic Ventures,
Christiansburg, Virginia, US) was used between samples to verify
the calibration and monitor measurement stability. Given the mass
density differences of the metal oxides and gold (ρTiO2 = 4.2 g cm
−3,
ρZrO2 = 5.7 g cm
−3, ρHfO2 = 9.7 g cm
−3, and ρAu = 19.3 g cm
−3), the
mass uptake was translated into number N of 5 nm nanoparticles per






, where VNP is the spherical nanoparticle volume
with radius r = 2.5 nm, ρNP is the density of the nanoparticle, and Mtot
is the total nanoparticle mass per cell.
Scanning Transmission Electron Microscopy (STEM) of
CellsSample Preparation, Imaging, and Analysis. For
imaging, 1.4 × 105 cells were seeded in 8 mL of culture medium in
a T25 cell culture flask. After overnight attachment, 700 μL of the
corresponding 1 mg mL−1 nanoparticle suspensions was added. After
a 24 h incubation time, the cells were washed with PBS, detached
using 1 mL of Accutase, washed, and fixed with 2.5% glutaraldehyde
in 0.1 M cacodylate buffer for 1.5 h. The cell pellets were stained with
2% osmium tetroxide and 1.5% potassium ferricyanide for 1 h,
gradually dehydrated using an ethanol gradient (50, 60, 70, 80, 90,
100, 100, and 100%), and embedded in epoxy resin (EPON 812 kit,
Sigma Aldrich), first together with ethanol (1:2 and 1:1, each for 3 h)
and subsequently with pure resin overnight. After another two resin
changes, each for 3 h, the resin blocks were cured in an oven at 60 °C
for 72 h, trimmed with a razor blade, and sectioned into sections with
100 nm thickness using an ultramicrotome. Sections were imaged
using a FEI Helios and FEI NanoSEM 230 scanning electron
microscope operated in transmission mode at 20 kV. The FEI Helios
instrument was equipped with a high annular dark-field detector. With
the FEI NanoSEM 230 instrument, a secondary electron and
backscattering electron detector were used. Electron micrographs
were analyzed using ImageJ (U.S. National Institutes of Health,
Bethesda, Maryland, USA). The intracellular nanoparticle agglomer-
ates were outlined (using thresholding) and analyzed (Feret
diameters: longest distance between any two points along the
selection boundary; total nanoparticle agglomerate area per cell).
Watershedding was used to break the assembled agglomerates.
Irradiation Setup. For irradiation of cells, a PMMA phantom was
assembled in-house with a recess in its volume center designed to fit a
48-well plate (TPP, Techno Plastic Products AG, Switzerland). The
phantom consisted of two equally sized slabs with dimensions of 4 ×
40 × 40 cm3 each, similar to the one described by Tesei et al.88 From
the center recess to one of the sides, an inlet was installed to fit a
dosimetry cable with 8 mm diameter. A calibrated ionization chamber
(N31003, PTW, Freiburg, Germany) connected to a UNIDOSwebline
dosimeter (PTW, Freiburg, Germany) was used to assess the dose
rate at the location of the cell plate recess before cell irradiation. This
item was placed next to the cell plate during irradiation to ensure dose
supply (see Figure S22 in the Supporting Information). A 12 mm
aluminum filter was placed on top of the phantom. A 450 kV X-ray
tube source (Seifert ISOVOLT 450, GE Sensing & Inspection
Technologies GmbH, Germany) was placed 50 cm above the bottom
phantom slab and used at a voltage of 150 kV and a current of 20 mA.
The dose rate at the point of the cell plate was 0.6 Gy min−1.
Cell Irradiation Experiments and Analysis. To study cell
survival after irradiation, 2000 cells (HT1080, HeLa or NHDF) in
290 μL of cell medium were seeded in a 48-well plate and allowed to
attach overnight. On the next day, 10 μL of a 0.2 or 1 mg mL−1
aqueous nanoparticle suspension or ultrapure water vehicle controls
was added to each well in quintuplets (n = 5, technical replicates) per
irradiation condition. For the comparison study of FSP vs WetChem
nanoparticles, experiments were performed in triplicate (n = 3) to fit
on one plate. After 24 h, the medium was removed by aspiration, and
the wells were washed with PBS (2×) and filled with 500 μL of fresh
medium. Thereafter, all plates were placed on ice and transported to
the irradiation facilities (45 min). After an equilibration phase of 30
min, the cell plates were irradiated with 0, 2, 4, 6, and 8 Gy, placed
back on ice for another 45 min, and placed in the culture incubator.
Medium (300 μL) was replaced every 2−4 days. After 7−8 days post-
irradiation, the control wells reached confluency, and a CellTiter-Glo
assay was performed using 90 μL of medium and 90 μL of CellTiter-
Glo reagent, similar to the viability assay described previously.
Samples were transferred from a transparent 48-well plate into a white
opaque 96-well plate for measurement in a plate reader, avoiding well-
to-well crosstalk. The luminescence signals were expressed relative to
the non-irradiated cells as
surviving fraction
(luminescence of irradiated cells background)






The data were fit to a linear quadratic model using MATLAB
(R2019b, The MathWorks, Inc., Natick, Massachusetts, United
States) as
surviving fraction e D D
2
= α β− −
where D is the exposed dose in Gy and α and β are the parameters
describing the cell radio-sensitivity.89 The data from the 0 Gy
exposure were used to calculate the long-term viability of 24 h
nanoparticle-treated cells compared with untreated cells.
In Vitro Dose Calculations and Size Measurements. For size
measurements of nanoparticles in cell medium, aqueous nanoparticle
suspensions (1 mg mL−1) were sonicated for 15 min and diluted in
fully supplemented medium to a final concentration of 33 μg mL−1
corresponding to the higher concentration used in irradiation
experiments. To calculate the bottom concentration of nanoparticles
in a 96-well or 48-well plate, a MATLAB code using the modified
distorted grid model supplied by DeLoid et al.67 was used. Model
inputs included material densities and effective agglomerate densities,
material size distributions (number-weighted) as measured by DLS,
media column height (3.0 mm for 100 μL in 96-well plates and 3.4
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mm for 300 μL in 48-well plates), media properties such as
temperature (37 °C), density, (ρmedia = 1.01 g cm
−3), and dynamic
viscosity (0.00081 Pa s), and administered (initial suspension) particle
concentration (33 μg mL−3 in the case of 48-well). The agglomerate
effective density was calculated with the sterling equation given by
DeLoid et al. using a fractal dimension DF = 2.3 and the z-average as
hydrodynamic diameter dH.
90 With the density of the media ρmedia and
of the particles ρp, the agglomerate effective density was calculated as
(1 )E a p a mediaρ ε ρ ε ρ= − +






is the agglomerate porosity. For the
cytotoxicity dosimetry calculations (96-well), sedimentation calcu-
lations were performed using only the number-weighted hydro-
dynamic diameter as input and was calculated as
d N d f d( ) N
i
N i H iH H , ,∑= ⟨ ⟩ =
where f N, i is the number fraction of each diameter dH, i.
91 Dosimetry
calculations corresponding to the irradiation experiments (48-well)
were performed using the full number-weighted size distribution as an
input.
Monte Carlo Simulations. The kilovoltage photon interactions
with a single nanoparticle and the total energy emission calculations
were kindly reported and provided by McMahon et al.73 In short,
McMahon et al. modeled the radiation−nanoparticle interactions and
the resulting radial dose distributions using Geant4 by placing
individual 20 nm diameter nanoparticles within the center of a cube of
water with 10 μm sides and allowing interaction with monoenergetic
keV X-rays (tuned to 20 keV above the K-edge). The resulting total
energy emission per ionizing event from a nanoparticle surface and its
contribution from electrons or photons for a Ti, Zr, and Hf
nanoparticle were calculated by summing the product of the electron
or photon spectra with their energy using MATLAB, reflecting those
values reported from the original paper.
HfO2 Scale-Up. The large batch of HfO2 nanopowder was
produced jointly with Avantama Ltd. by providing them with the
precursor recipe. HfO2 was prepared by flame spray synthesis using a
precursor solution of hafnium isopropoxide (Alfa Aesar H52288) in 2-
ethylhexanoic acid (SAFC Q64930), and the solution was diluted
with 30 wt % xylene. The precursor was fed (7 mL min−1; HNP
Mikrosysteme 4605, micro annular gear pump) to a spray nozzle,
dispersed by oxygen (13 L min−1), and ignited by a premixed
methane−oxygen flame (CH4: 1.2 L min−1 and O2: 2.2 L min−1, both
Messer AG). The off-gas was filtered through a steel mesh filter (20
micron mesh size) using a vacuum pump (Busch Mink MM 1142BV)
at approximately 30 m 3 h−1. The obtained dry HfO2 nanopowder
was collected from the filter mesh. The characterization, cytotoxicity,
and radio-enhancement efficacies were measured according to the
aforementioned procedures, with slight adaptions (dose rate of 1.2 Gy
min−1 using a 2 mm aluminum filter). To compare the scale-up batch
to the lab batch, radio-enhancement efficiencies in HT1080 cells were
assessed 4 days post-irradiation based on the above protocols.
■ ASSOCIATED CONTENT
*sı Supporting Information
The Supporting Information is available free of charge at
https://pubs.acs.org/doi/10.1021/acs.chemmater.0c04565.
(Table S1) d-spacings from HRTEM pictures; (Table
S2) XRD sizes; (Table S3) average hydrodynamic
diameters; (Table S4) comparison of Au NP uptake
into cells; (Table S5) D50% and DMR50% values for all
NPs; (Figure S1) XRD patterns; (Figure S2) Rietveld
refinement; (Figure S3) TEM and XRD for ZrO2 as a
function of reaction time; (Figure S4) TGA and DTG
data; (Figure S5) DLS in medium and dosimetry
calculations; (Figure S6) photographs of NP suspen-
sions; (Figure S7) UV-sedimentation data; (Figure S8)
TEM micrographs of air-dried NP suspensions; (Figure
S9) HeLa toxicity; (Figure S10) NHDF toxicity; (Figure
S11) nanoparticle cellular uptake for HeLa and NHDF
cell lines; (Figure S12) STEM images of cellular uptake;
(Figure S13) intracellular NP area fraction; (Figure S14)
long-term toxicity HT1080; (Figure S15) long-term
toxicity for all cell lines; (Figure S16) survival fractions
and toxicity effect for differently sized gold nano-
particles; (Figure S17) dose enhancement efficiency of
nanoparticles in HeLa cells; (Figure S18) survival
fraction summary; (Figure S19) comparison between
clonogenic and metabolic assay; (Figure S20) phys-
icochemical characteristics of upscaled batch; (Figure
S21) survival fraction for lab and upscaled batch; and
(Figure S22) irradiation setup (PDF)
■ AUTHOR INFORMATION
Corresponding Author
Inge K. Herrmann − Nanoparticle Systems Engineering
Laboratory, Institute of Energy and Process Engineering
(IEPE), Department of Mechanical and Process Engineering
(D-MAVT), ETH Zurich, 8092 Zurich, Switzerland;
Particles-Biology Interactions, Department of Materials Meet
Life, Swiss Federal Laboratories for Materials Science and
Technology (Empa), 9014 St. Gallen, Switzerland;
orcid.org/0000-0002-3018-6796; Phone: +41 (0)58
765 7153; Email: inge.herrmann@empa.ch, ingeh@
ethz.ch
Authors
Lukas R.H. Gerken − Nanoparticle Systems Engineering
Laboratory, Institute of Energy and Process Engineering
(IEPE), Department of Mechanical and Process Engineering
(D-MAVT), ETH Zurich, 8092 Zurich, Switzerland;
Particles-Biology Interactions, Department of Materials Meet
Life, Swiss Federal Laboratories for Materials Science and
Technology (Empa), 9014 St. Gallen, Switzerland
Anna L. Neuer − Nanoparticle Systems Engineering
Laboratory, Institute of Energy and Process Engineering
(IEPE), Department of Mechanical and Process Engineering
(D-MAVT), ETH Zurich, 8092 Zurich, Switzerland;
Particles-Biology Interactions, Department of Materials Meet
Life, Swiss Federal Laboratories for Materials Science and
Technology (Empa), 9014 St. Gallen, Switzerland
Pascal M. Gschwend − Particle Technology Laboratory,
Institute of Energy and Process Engineering (IEPE),
Department of Mechanical and Process Engineering (D-
MAVT), ETH Zurich, CH-8092 Zurich, Switzerland;
orcid.org/0000-0002-5980-1959
Kerda Keevend − Nanoparticle Systems Engineering
Laboratory, Institute of Energy and Process Engineering
(IEPE), Department of Mechanical and Process Engineering
(D-MAVT), ETH Zurich, 8092 Zurich, Switzerland;
Particles-Biology Interactions, Department of Materials Meet
Life, Swiss Federal Laboratories for Materials Science and
Technology (Empa), 9014 St. Gallen, Switzerland
Alexander Gogos − Particles-Biology Interactions, Department
of Materials Meet Life, Swiss Federal Laboratories for
Materials Science and Technology (Empa), 9014 St. Gallen,
Switzerland
Alexandre H.C. Anthis − Nanoparticle Systems Engineering
Laboratory, Institute of Energy and Process Engineering
Chemistry of Materials pubs.acs.org/cm Article
https://doi.org/10.1021/acs.chemmater.0c04565
Chem. Mater. 2021, 33, 3098−3112
3109
(IEPE), Department of Mechanical and Process Engineering
(D-MAVT), ETH Zurich, 8092 Zurich, Switzerland;
Particles-Biology Interactions, Department of Materials Meet
Life, Swiss Federal Laboratories for Materials Science and
Technology (Empa), 9014 St. Gallen, Switzerland
Leonie Aengenheister − Particles-Biology Interactions,
Department of Materials Meet Life, Swiss Federal
Laboratories for Materials Science and Technology (Empa),
9014 St. Gallen, Switzerland
Sotiris E. Pratsinis − Particle Technology Laboratory, Institute
of Energy and Process Engineering (IEPE), Department of
Mechanical and Process Engineering (D-MAVT), ETH
Zurich, CH-8092 Zurich, Switzerland
Ludwig Plasswilm − Department of Radiation Oncology,
Cantonal Hospital St. Gallen (KSSG), CH-9007 St. Gallen,
Switzerland; University of Bern, CH-3010 Bern, Switzerland
Complete contact information is available at:
https://pubs.acs.org/10.1021/acs.chemmater.0c04565
Author Contributions
L.R.H. contributed to the study design, performed experi-
ments, analyzed data, and drafted the manuscript. A.L.N.
helped with irradiation experiments and performed the
clonogenic assay. P.M.G., K.K., and A.H.C.A. helped with
nanoparticle synthesis and characterization. A.G. developed
and performed elemental analysis protocols and acquired
STEM of cells. L.A. helped with hydrofluoric acid digestion of
nanoparticles. S.E.P. and L.P. actively provided input. I.K.H.
conceived and supervised the study and edited the manuscript.
All authors contributed to the manuscript writing and have
given approval to the final version of the manuscript.
Notes
The authors declare no competing financial interest.
Parts of the schematics in Figure 1, and the TOC were created
using BioRender.com.
■ ACKNOWLEDGMENTS
The authors acknowledge the Scientific Center for Optical and
Electron Microscopy (Scope M) of ETH Zurich and the Empa
Microscopy Center for support in ultramicrotome sectioning
and access to their microscopes. We thank the Empa Center
for X-ray Analytics for access to their facilities and Ralf Kägi
and Brian Sinnet at the Swiss Federal Institute of Aquatic
Science and Technology (EAWAG) for access to their HF-
digestion facilities. This study was funded in parts by the Swiss
National Science Foundation (Eccellenza grant no. 181290),
the Swiss Cancer League (KFS-4868-08-2019), the Olga
Mayenfisch Foundation and Seed Money from the Empa-
Cantonal Hospital St. Gallen (KSSG) program. P.M.G. and
S.E.P. acknowledge funding from the Swiss National Science
Foundation (grant nos. 182668 and 183298).
■ REFERENCES
(1) Stone, H. B.; Coleman, C. N.; Anscher, M. S.; McBride, W. H.
Effects of Radiation on Normal Tissue: Consequences and
Mechanisms. Lancet Oncol. 2003, 4, 529−536.
(2) Corradini, S.; Alongi, F.; Andratschke, N.; Belka, C.; Boldrini, L.;
Cellini, F.; Debus, J.; Guckenberger, M.; Hörner-Rieber, J.;
Lagerwaard, F. J.; Mazzola, R.; Palacios, M. A.; Philippens, M. E.
P.; Raaijmakers, C. P. J.; Terhaard, C. H. J.; Valentini, V.; Niyazi, M.
MR-Guidance in Clinical Reality: Current Treatment Challenges and
Future Perspectives. Radiat. Oncol. 2019, 14, 92.
(3) Baskar, R.; Lee, K. A.; Yeo, R.; Yeoh, K.-W. Cancer and
Radiation Therapy: Current Advances and Future Directions. Int. J.
Med. Sci. 2012, 9, 193−199.
(4) Rehman, J. u.; Zahra; Ahmad, N.; Khalid, M.; Asghar, H. M. N.
u.; Gilani, Z. A.; Ullah, I.; Nasar, G.; Akhtar, M. M.; Usmani, M. N.
Intensity Modulated Radiation Therapy: A Review of Current
Practice and Future Outlooks. J. Radiat. Res. Appl. Sci. 2018, 11,
361−367.
(5) Cui, L.; Her, S.; Borst, G. R.; Bristow, R. G.; Jaffray, D. A.; Allen,
C. Radiosensitization by Gold Nanoparticles: Will They Ever Make It
to the Clinic? Radiother. Oncol. 2017, 124, 344−356.
(6) Caffo, O. Radiosensitization with Chemotherapeutic Agents.
Lung Cancer 2001, 34, 81−90.
(7) Mierzwa, M. L.; Nyati, M. K.; Morgan, M. A.; Lawrence, T. S.
Recent Advances in Combined Modality Therapy. Oncologist 2010,
15, 372−381.
(8) Kwatra, D.; Venugopal, A.; Anant, S. Nanoparticles in Radiation
Therapy: A Summary of Various Approaches to Enhance Radio-
sensitization in Cancer. Transl. Cancer Res. 2013, 2, 330−342.
(9) Butterworth, K. T.; McMahon, S. J.; Currell, F. J.; Prise, K. M.
Physical Basis and Biological Mechanisms of Gold Nanoparticle
Radiosensitization. Nanoscale 2012, 4, 4830−4838.
(10) Guerreiro, A.; Chatterton, N.; Crabb, E. M.; Golding, J. P. A
Comparison of the Radiosensitisation Ability of 22 Different Element
Metal Oxide Nanoparticles Using Clinical Megavoltage X-Rays.
Cancer Nanotechnol. 2019, 10, 10.
(11) Vilotte, F.; Jumeau, R.; Bourhis, J. High Z Nanoparticles and
Radiotherapy: A Critical View. Lancet Oncol. 2019, 20, No. e557.
(12) Howard, D.; Sebastian, S.; Le, Q. V.-C.; Thierry, B.; Kempson,
I. Chemical Mechanisms of Nanoparticle Radiosensitization and
Radioprotection: A Review of Structure-Function Relationships
Influencing Reactive Oxygen Species. Int. J. Mol. Sci. 2020, 21, 579.
(13) Retif, P.; Pinel, S.; Toussaint, M.; Frochot, C.; Chouikrat, R.;
Bastogne, T.; Barberi-Heyob, M. Nanoparticles for Radiation Therapy
Enhancement: The Key Parameters. Theranostics 2015, 5, 1030−
1044.
(14) Cooper, D. R.; Bekah, D.; Nadeau, J. L. Gold Nanoparticles and
Their Alternatives for Radiation Therapy Enhancement. Front. Chem.
2014, 2, 86.
(15) Bonvalot, S.; Le Pechoux, C.; De Baere, T.; Kantor, G.; Buy, X.;
Stoeckle, E.; Terrier, P.; Sargos, P.; Coindre, J. M.; Lassau, N.; Ait
Sarkouh, R.; Dimitriu, M.; Borghi, E.; Levy, L.; Deutsch, E.; Soria, J.-
C. First-In-Human Study Testing a New Radioenhancer Using
Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients
with Locally Advanced Soft Tissue Sarcomas. Clin. Cancer Res. 2017,
23, 908−917.
(16) Bonvalot, S.; Rutkowski, P. L.; Thariat, J.; Carrer̀e, S.;
Ducassou, A.; Sunyach, M.-P.; Agoston, P.; Hong, A.; Mervoyer, A.;
Rastrelli, M.; Moreno, V.; Li, R. K.; Tiangco, B.; Herraez, A. C.;
Gronchi, A.; Mangel, L.; Sy-Ortin, T.; Hohenberger, P.; de Baer̀e, T.;
Le Cesne, A.; Helfre, S.; Saada-Bouzid, E.; Borkowska, A.; Anghel, R.;
Co, A.; Gebhart, M.; Kantor, G.; Montero, A.; Loong, H. H.; Vergés,
R.; Lapeire, L.; Dema, S.; Kacso, G.; Austen, L.; Moureau-Zabotto, L.;
Servois, V.; Wardelmann, E.; Terrier, P.; Lazar, A. J.; Bovée, J. V. M.
G.; Le Péchoux, C.; Papai, Z. NBTXR3, a First-In-Class Radio-
enhancer Hafnium Oxide Nanoparticle, plus Radiotherapy versus
Radiotherapy Alone in Patients with Locally Advanced Soft-Tissue
Sarcoma (Act.In.Sarc): A Multicentre, Phase 2−3, Randomised,
Controlled Trial. Lancet Oncol 2019, 20, 1148−1159.
(17) Anselmo, A. C.; Mitragotri, S. Nanoparticles in the Clinic: An
Update. Bioeng. Transl. Med. 2019, 4, No. e10143.
(18) Herrmann, I. K.; Rösslein, M. Personalized Medicine: The
Enabling Role of Nanotechnology. Nanomedicine 2016, 11, 1−3.
(19) Rösslein, M.; Liptrott, N. J.; Owen, A.; Boisseau, P.; Wick, P.;
Herrmann, I. K. Sound Understanding of Environmental, Health and
Safety, Clinical, and Market Aspects Is Imperative to Clinical
Translation of Nanomedicines. Nanotoxicology 2017, 11, 147−149.
(20) Ricketts, K.; Ahmad, R.; Beaton, L.; Cousins, B.; Critchley, K.;
Davies, M.; Evans, S.; Fenuyi, I.; Gavriilidis, A.; Harmer, Q. J.; Jayne,
Chemistry of Materials pubs.acs.org/cm Article
https://doi.org/10.1021/acs.chemmater.0c04565
Chem. Mater. 2021, 33, 3098−3112
3110
D.; Jefford, M.; Loizidou, M.; Macrobert, A.; Moorcroft, S.; Naasani,
I.; Ong, Z. Y.; Prise, K. M.; Rannard, S.; Richards, T.; Schettino, G.;
Sharma, R. A.; Tillement, O.; Wakefield, G.; Williams, N. R.; Yaghini,
E.; Royle, G. Recommendations for Clinical Translation of Nano-
particle-Enhanced Radiotherapy. Br. J. Radiol. 2018, 91, 20180325.
(21) Starsich, F. H. L.; Herrmann, I. K.; Pratsinis, S. E.
Nanoparticles for Biomedicine: Coagulation During Synthesis and
Applications. Annu. Rev. Chem. Biomol. Eng. 2019, 10, 155−174.
(22) Nikam, A. V.; Prasad, B. L. V.; Kulkarni, A. A. Wet Chemical
Synthesis of Metal Oxide Nanoparticles: A Review. CrystEngComm
2018, 20, 5091−5107.
(23) Deshmukh, R.; Niederberger, M. Nonhydrolytic Sol-Gel
Methods. In The Sol-Gel Handbook; Levy, D., Zayat, M. Eds.;
Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2015;
pp 29−70.
(24) Mueller, R.; Jossen, R.; Pratsinis, S. E.; Watson, M.; Akhtar, M.
K. Zirconia Nanoparticles Made in Spray Flames at High Production
Rates. J. Am. Ceram. Soc. 2004, 87, 197−202.
(25) Mueller, R.; Mädler, L.; Pratsinis, S. E. Nanoparticle Synthesis
at High Production Rates by Flame Spray Pyrolysis. Chem. Eng. Sci.
2003, 58, 1969−1976.
(26) Starsich, F. H. L.; Gschwend, P.; Sergeyev, A.; Grange, R.;
Pratsinis, S. E. Deep Tissue Imaging with Highly Fluorescent Near-
Infrared Nanocrystals after Systematic Host Screening. Chem. Mater.
2017, 29, 8158−8166.
(27) Mädler, L.; Stark, W. J.; Pratsinis, S. E. Flame-Made Ceria
Nanoparticles. J. Mater. Res. 2002, 17, 1356−1362.
(28) Teoh, W. Y.; Amal, R.; Mädler, L. Flame Spray Pyrolysis: An
Enabling Technology for Nanoparticles Design and Fabrication.
Nanoscale 2010, 2, 1324−1347.
(29) Mädler, L.; Kammler, H. K.; Mueller, R.; Pratsinis, S. E.
Controlled Synthesis of Nanostructured Particles by Flame Spray
Pyrolysis. J. Aerosol Sci. 2002, 33, 369−389.
(30) Koirala, R.; Pratsinis, S. E.; Baiker, A. Synthesis of Catalytic
Materials in Flames: Opportunities and Challenges. Chem. Soc. Rev.
2016, 45, 3053−3068.
(31) Keevend, K.; Panzarasa, G.; Starsich, F. H. L.; Zeltner, M.;
Spyrogianni, A.; Tsolaki, E.; Fortunato, G.; Pratsinis, S. E.; Bertazzo,
S.; Herrmann, I. K. Facile MeltPEGylation of Flame-Made
Luminescent Tb3+-Doped Yttrium Oxide Particles: Hemocompati-
bility, Cellular Uptake and Comparison to Silica. Chem. Commun.
2018, 54, 2914−2917.
(32) Eggenhuisen, T. M.; Munnik, P.; Talsma, H.; de Jongh, P. E.;
de Jong, K. P. Freeze-Drying for Controlled Nanoparticle Distribution
in Co/SiO2 Fischer−Tropsch Catalysts. J. Catal. 2013, 297, 306−313.
(33) Wang, B.; Zhang, W.; Zhang, W.; Mujumdar, A. S.; Huang, L.
Progress in Drying Technology for Nanomaterials. Drying Technol.
2005, 23, 7−32.
(34) Athanassiou, E. K.; Grass, R. N.; Stark, W. J. Chemical Aerosol
Engineering as a Novel Tool for Material Science: From Oxides to
Salt and Metal Nanoparticles. Aerosol Sci. Technol. 2010, 44, 161−172.
(35) Grass, R. N.; Stark, W. J. Flame Synthesis of Calcium-,
Strontium-, Barium Fluoride Nanoparticles and Sodium Chloride.
Chem. Commun. 2005, 13, 1767−1769.
(36) Grass, R. N.; Stark, W. J. Gas Phase Synthesis of Fcc-Cobalt
Nanoparticles. J. Mater. Chem. 2006, 16, 1825−1830.
(37) Gioria, S.; Caputo, F.; Urbán, P.; Maguire, C. M.; Bremer-
Hoffmann, S.; Prina-Mello, A.; Calzolai, L.; Mehn, D. Are Existing
Standard Methods Suitable for the Evaluation of Nanomedicines:
Some Case Studies. Nanomedicine 2018, 13, 539−554.
(38) Garnweitner, G.; Niederberger, M. Nonaqueous and
Surfactant-Free Synthesis Routes to Metal Oxide Nanoparticles. J.
Am. Ceram. Soc. 2006, 89, 1801−1808.
(39) Garnweitner, G.; Goldenberg, L. M.; Sakhno, O. V.; Antonietti,
M.; Niederberger, M.; Stumpe, J. Large-Scale Synthesis of Organo-
philic Zirconia Nanoparticles and Their Application in Organic−
Inorganic Nanocomposites for Efficient Volume Holography. Small
2007, 3, 1626−1632.
(40) Zhou, S.; Garnweitner, G.; Niederberger, M.; Antonietti, M.
Dispersion Behavior of Zirconia Nanocrystals and Their Surface
Functionalization with Vinyl Group-Containing Ligands. Langmuir
2007, 23, 9178−9187.
(41) Villa, I.; Villa, C.; Monguzzi, A.; Babin, V.; Tervoort, E.; Nikl,
M.; Niederberger, M.; Torrente, Y.; Vedda, A.; Lauria, A.
Demonstration of Cellular Imaging by Using Luminescent and
Anti-Cytotoxic Europium-Doped Hafnia Nanocrystals. Nanoscale
2018, 10, 7933−7940.
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